SCHEMBL7042008

SCHEMBL7042008

COC(=O)Cc1ccc(CC#CCO)cc1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.59
CYP4A11 Q02928 1/20 0.59
ALDH1A1 P00352 4/20 0.45
GAA P10253 1/20 0.45
GFER P55789 1/20 0.45
HSP90AB1 P08238 1/20 0.44
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 5/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
MAPT P10636 3/20 0.42
TP53 P04637 2/20 0.42
LMNA P02545 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971051 0.86 CYP4F2 (0.54) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL4579260 0.85 CYP4F2 (0.57) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL8787884 0.84 CYP4F2 (0.56) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL8787287 0.84 CYP4F2 (0.56) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL4972200 0.84 SLC7A5 (0.52) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL4113212 0.81 CYP4F2 (0.76) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL9647592 0.80 CYP4F2 (0.59) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL3816589 0.79 LOXL2 (0.56) CYP4F2CYP4A11ALDH1A1GAAKMT2A
SCHEMBL5844094 0.79 CYP4F2 (0.58) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL7461859 0.78 FFAR1 (0.53) ALDH1A1GAAKMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed